Exploration of pharmacodynamic substances and potential mechanisms of Huazhuo Sanjie Chubi Decoction in treatment of gouty arthritis based on UPLC-Q-Exactive Orbitrap-MS technology and network pharmacology.
10.19540/j.cnki.cjcmm.20241025.201
- Author:
Yan XIAO
1
;
Ting ZHANG
2
;
Ying-Jie ZHANG
2
;
Bin HUANG
3
;
Peng CHEN
2
;
Xiao-Hua CHEN
4
;
Ming-Qing HUANG
5
;
Xue-Ting CHEN
5
;
You-Xin SU
6
;
Jie-Mei GUO
6
Author Information
1. College of Rehabilitation Medicine,Fujian University of Traditional Chinese Medicine Fuzhou 350122,China.
2. College of Traditional Chinese Medicine,Fujian University of Traditional Chinese Medicine Fuzhou 350122,China Key Laboratory of Orthopedics&Traumatology of Traditional Chinese Medicine and Rehabilitation,Ministry of Education Fuzhou 350122,China.
3. Academy of Intergrative Medicine,College of Intergrative Medicine,Fujian University of Traditional Chinese Medicine Fuzhou 350122,China.
4. First Clinical Medicine College,Fujian University of Traditional Chinese Medicine Fuzhou 350004,China.
5. College of Pharmacy,Fujian University of Traditional Chinese Medicine Fuzhou 350122,China.
6. Key Laboratory of Orthopedics&Traumatology of Traditional Chinese Medicine and Rehabilitation,Ministry of Education Fuzhou 350122,China.
- Publication Type:Journal Article
- Keywords:
Huazhuo Sanjie Chubi Decoction;
UPLC-Q-Exactive Orbitrap-MS;
gouty arthritis;
mechanism;
network pharmacology;
pharmacodynamic substances
- MeSH:
Drugs, Chinese Herbal/therapeutic use*;
Network Pharmacology;
Arthritis, Gouty/metabolism*;
Chromatography, High Pressure Liquid/methods*;
Humans;
Mass Spectrometry/methods*;
Protein Interaction Maps/drug effects*
- From:
China Journal of Chinese Materia Medica
2025;50(2):444-488
- CountryChina
- Language:Chinese
-
Abstract:
Based on ultra-high performance liquid chromatography-quadrupole-Exactive Orbitrap mass spectrometry(UPLC-Q-Exactive Orbitrap-MS) technology and network pharmacology, this study explored the pharmacodynamic substances and potential mechanisms of Huazhuo Sanjie Chubi Decoction in the treatment of gouty arthritis(GA). UPLC-Q-Exactive Orbitrap-MS technology was used to identify the components in Huazhuo Sanjie Chubi Decoction, and the qualitative analysis of its active ingredients was carried out, with a total of 184 active ingredients identified. A total of 897 active ingredient targets were screened through the PharmMapper database, and 491 GA-related disease targets were obtained from the OMIM, GeneCards, CTD databases. After Venn analysis, 60 intersecting targets were obtained. The component target-GA target network was constructed through the Cytoscape platform, and the STRING database was used to construct a protein-protein interaction network, with 16 core targets screened. The core targets were subjected to Gene Ontology(GO) and Kyoto Encyclopedia of Genes and Genomes(KEGG) pathway enrichment analyses, and the component-target-pathway network was constructed. It was found that the main active ingredients of the formula for the treatment of GA were phenols, flavonoids, alkaloids, and terpenoids, and the key targets were SRC, MMP3, MMP9, REN, ALB, IGF1R, PPARG, MAPK1, HPRT1, and CASP1. Through GO analysis, it was found that the treatment of GA mainly involved biological processes such as lipid response, bacterial response, and biostimulus response. KEGG analysis showed that the pathways related to the treatment of GA included lipids and atherosclerosis, neutrophil extracellular traps(NETs), IL-17, and so on. In summary, phenols, flavonoids, alkaloids, and terpenoids may be the core pharmacodynamic substances of Huazhuo Sanjie Chubi Decoction in the treatment of GA, and the pharmacodynamic mechanism may be related to SRC, MMP3, MMP9, and other targets, as well as lipids and atherosclerosis, NETs, IL-17, and other pathways.
